{"id":983295,"date":"2026-07-21T10:39:46","date_gmt":"2026-07-21T14:39:46","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/gral-upcoming-deadline-suewallst-alerts-grail-inc-stockholders-of-securities-class-action\/"},"modified":"2026-07-21T10:39:46","modified_gmt":"2026-07-21T14:39:46","slug":"gral-upcoming-deadline-suewallst-alerts-grail-inc-stockholders-of-securities-class-action","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gral-upcoming-deadline-suewallst-alerts-grail-inc-stockholders-of-securities-class-action\/","title":{"rendered":"GRAL UPCOMING DEADLINE: SueWallSt Alerts Grail, Inc. Stockholders of Securities Class Action"},"content":{"rendered":"

\nImportant Information Regarding Section 20(a) Individual Liability Claims: Grail CEO and President Personally Named in Securities Action After NHS-Galleri Trial Failure Cost Investors $51.32 Per Share
\n<\/h2>\n
\n

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) — SueWallSt alerts investors in Grail, Inc. (NASDAQ: GRAL) of a pending securities class action naming senior executives as individual defendants. Class Period: May 13, 2025 through February 19, 2026.\u00a0Find out if you could qualify to recover your losses<\/u><\/a> or contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com<\/u><\/a> | (888) SueWallSt.<\/p>\n

GRAL shares lost $51.32 per share, a 50.55% single-day collapse, after the Company revealed its NHS-Galleri trial failed to achieve its primary endpoint. The Court has set August 4, 2026 as the deadline to apply for lead plaintiff appointment.<\/p>\n

\n The Named Individual Defendants<\/strong>\n <\/p>\n

Multiple senior officers of Grail are named as individual defendants in this securities class action. Robert P. Ragusa, Chief Executive Officer and Director throughout the Class Period, and Joshua J. Ofman, President throughout the Class Period, each allegedly possessed the power and authority to control the contents of Grail’s SEC filings, press releases, and presentations to analysts and institutional investors. The action contends both executives were provided with copies of the Company’s public statements prior to issuance and had the ability to prevent their release or cause them to be corrected.<\/p>\n

\n Section 20(a) Control Person Framework<\/strong>\n <\/p>\n

The complaint asserts claims under Section 20(a) of the Securities Exchange Act of 1934, which imposes liability on individuals who act as “controlling persons” of a company that violates federal securities laws. Control person liability does not require proof that the individual personally made a false statement. Rather, it requires that the individual had the power to direct or cause the direction of the company’s management and policies.<\/p>\n